SCHEMBL7140080

SCHEMBL7140080

CO/C=C(/C(=O)O)c1ccccc1C=C/C=C/c1ccc(F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40
TUBA4A P68366 1/20 0.40
TUBB4B P68371 1/20 0.40
TUBB3 Q13509 1/20 0.40
TUBB2A Q13885 1/20 0.40
TUBB8 Q3ZCM7 1/20 0.40
TUBA3E Q6PEY2 1/20 0.40
TUBA1A Q71U36 1/20 0.40
TUBA1C Q9BQE3 1/20 0.40
TUBB6 Q9BUF5 1/20 0.40
TUBB2B Q9BVA1 1/20 0.40
TUBB1 Q9H4B7 1/20 0.40
MAOB P27338 6/20 0.40
MAOA P21397 3/20 0.40
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7140078 1.00 TUBB4A (0.40) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7139094 0.91 MAOB (0.42) MAOBMAOAMEN1KMT2AALDH1A1
SCHEMBL7139096 0.91 MAOB (0.42) MAOBMAOAMEN1KMT2AALDH1A1
SCHEMBL7136432 0.88 MAOB (0.46) MAOBMAOAMEN1POLBKMT2A
SCHEMBL7143686 0.88 MAOB (0.52) MAOBMAOAMEN1KMT2AALDH1A1
SCHEMBL7136433 0.88 MAOB (0.46) MAOBMAOAMEN1POLBKMT2A
SCHEMBL7143682 0.88 MAOB (0.52) MAOBMAOAMEN1KMT2AALDH1A1
SCHEMBL7135385 0.87 TRPA1 (0.42) MAOBTRPA1NFE2L2
SCHEMBL7135382 0.87 TRPA1 (0.42) MAOBTRPA1NFE2L2
SCHEMBL7141749 0.87 AKR1C2 (0.44) MAOBMEN1KMT2ANFE2L2AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996439-B1 BETA-ALKOXYACRYLATES AGAINST MALARIA HOFFMANN LA ROCHE (CH) 2003-01-08 EP disclosed
US-6084120-A ACTIVE AGAINST CHLOROQUINE-SENSITIVE PATIENTS AND AGAINST CHLOROQUINE-RESISTANT MALARIA PATHOGENS; PROPHYLAXIS AND TREATMENT; E.G., A 3 METHOXY-2-(2-(4-PHENYLBUTA-1,3-DIEN-1-YL)PHENYL)ACRYLIC ACID HOFFMANN-LA ROCHE INC. (US) 2000-07-04 US disclosed